Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xiao‑Fei Ding
VHL Loss Predicts Response to Aurora Kinase a Inhibitor in Renal Cell Carcinoma Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Related publications
-Catenin Links Von Hippel-Lindau to Aurora Kinase a and Loss of Primary Cilia in Renal Cell Carcinoma
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
MYC Activation Cooperates With VHL and Ink4a/Arf Loss to Induce Clear Cell Renal Cell Carcinoma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Insights Into Epigenetic Remodeling in VHL-Deficient Clear Cell Renal Cell Carcinoma
Cancer Discovery
Oncology
The VHL-HIF Signaling in Renal Cell Carcinoma: Promises and Pitfalls
High Expression of FER Tyrosine Kinase Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
Oncology Letters
Cancer Research
Oncology
The Role of VHL in Clear-Cell Renal Cell Carcinoma and Its Relation to Targeted Therapy
Kidney International
Nephrology
Clinical Benefit to an Aurora a Kinase Inhibitor in a Patient With Metastatic Integrase Interactor 1‐Deficient Carcinoma
Oncologist
Cancer Research
Medicine
Oncology
Inactivation of the PBRM1 Tumor Suppressor Gene Amplifies the HIF-response in VHL−/−clear Cell Renal Carcinoma
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The Aurora-Kinase a Phe31-Ile Polymorphism as Possible Predictor of Response to Treatment in Head and Neck Squamous Cell Carcinoma
Oncotarget
Oncology